Richard E. Olson,Angela M. Cacace,Peter Hagedorn,Anja Mølhart Høg,Dong Li,Jeffrey M. Brown,Marianne Lerbech Jensen,Niels Fisker Nielsen,Stephen E. Mercer
申请号：
US15016169
公开号：
US10799523B2
申请日:
2016.02.04
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to oligomer compounds (oligomers), which target Tau mRNA in a cell, leading to reduced expression of Tau protein. Reduction of Tau protein expression is beneficial for the treatment of certain medical disorders, e.g., a neurological disorder.
